United Therapeutics buy Cantor Fitzgerald
Start price
02.06.25
/
50%
€283.30
Target price
02.06.26
€356.20
Performance (%)
-12.11%
Price
04.07.25
€249.00
Summary
This prediction is currently active. The prediction for United Therapeutics disappoints with a performance of -12.11%. This prediction currently runs until 02.06.26. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
United Therapeutics | 2.596% | 2.596% |
iShares Core DAX® | -1.315% | -2.266% |
iShares Nasdaq 100 | 0.272% | 1.449% |
iShares Nikkei 225® | -2.496% | 1.560% |
iShares S&P 500 | 0.504% | 1.340% |
Comments by Cantor_Fitzgerald for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics Co. (NASDAQ: UTHR) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $405.00 price target on the stock.
Ratings data for UTHR provided by MarketBeat